A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate.

Authors :: Ebisawa K
Masamoto Y
Yagi K
Kurokawa M
Source :: Annals of hematology [Ann Hematol] 2022 Nov; Vol. 101 (11), pp. 2551-2552. Date of Electronic Publication: 2022 Aug 06.
Publication Year :: 2022

Subjects :: Humans
Imatinib Mesylate therapeutic use
Janus Kinase 2 genetics
Mutation
Polycythemia Vera
Thrombocythemia, Essential drug therapy
Thrombocythemia, Essential genetics

Full Text Access

Tools